X‐linked adrenoleukodystrophy: pathology, pathophysiology, diagnostic testing, newborn screening and therapies

BR Turk, C Theda, A Fatemi… - International Journal of …, 2020 - Wiley Online Library
Adrenoleukodystrophy (ALD) is a rare X‐linked disease caused by a mutation of the
peroxisomal ABCD1 gene. This review summarizes our current understanding of the …

[HTML][HTML] The peroxisome: an update on mysteries 2.0

M Islinger, A Voelkl, HD Fahimi, M Schrader - Histochemistry and cell …, 2018 - Springer
Peroxisomes are key metabolic organelles, which contribute to cellular lipid metabolism, eg
the β-oxidation of fatty acids and the synthesis of myelin sheath lipids, as well as cellular …

[HTML][HTML] Malnutrition-associated liver steatosis and ATP depletion is caused by peroxisomal and mitochondrial dysfunction

T van Zutphen, J Ciapaite, VW Bloks, C Ackereley… - Journal of …, 2016 - Elsevier
Background & Aims Severe malnutrition in young children is associated with signs of hepatic
dysfunction such as steatosis and hypoalbuminemia, but its etiology is unknown …

Peroxisome-mitochondria interplay and disease

M Schrader, J Costello, LF Godinho… - Journal of inherited …, 2015 - Springer
Peroxisomes and mitochondria are ubiquitous, highly dynamic organelles with an oxidative
type of metabolism in eukaryotic cells. Over the years, substantial evidence has been …

[HTML][HTML] Peroxisomes in brain development and function

J Berger, F Dorninger, S Forss-Petter… - Biochimica Et Biophysica …, 2016 - Elsevier
Peroxisomes contain numerous enzymatic activities that are important for mammalian
physiology. Patients lacking either all peroxisomal functions or a single enzyme or …

How the brain fights fatty acids' toxicity

P Schönfeld, G Reiser - Neurochemistry International, 2021 - Elsevier
Neurons spurn hydrogen-rich fatty acids for energizing oxidative ATP synthesis, contrary to
other cells. This feature has been mainly attributed to a lower yield of ATP per reduced …

Oxidative stress and mitochondrial dysfunction across broad‐ranging pathologies: toward mitochondria‐targeted clinical strategies

G Pagano, A Aiello Talamanca… - Oxidative medicine …, 2014 - Wiley Online Library
Beyond the disorders recognized as mitochondrial diseases, abnormalities in function
and/or ultrastructure of mitochondria have been reported in several unrelated pathologies …

Brain energy metabolism spurns fatty acids as fuel due to their inherent mitotoxicity and potential capacity to unleash neurodegeneration

P Schönfeld, G Reiser - Neurochemistry international, 2017 - Elsevier
The brain uses long-chain fatty acids (LCFAs) to a negligible extent as fuel for the
mitochondrial energy generation, in contrast to other tissues that also demand high energy …

The brain penetrant PPARγ agonist leriglitazone restores multiple altered pathways in models of X-linked adrenoleukodystrophy

L Rodríguez-Pascau, A Vilalta, M Cerrada… - Science Translational …, 2021 - science.org
X-linked adrenoleukodystrophy (X-ALD), a potentially fatal neurometabolic disorder with no
effective pharmacological treatment, is characterized by clinical manifestations ranging from …

[HTML][HTML] N-acetylcysteine pharmacology and applications in rare diseases—Repurposing an old antioxidant

SA Sahasrabudhe, MR Terluk, RV Kartha - Antioxidants, 2023 - mdpi.com
N-acetylcysteine (NAC), a precursor of cysteine and, thereby, glutathione (GSH), acts as an
antioxidant through a variety of mechanisms, including oxidant scavenging, GSH …